118 related articles for article (PubMed ID: 37622669)
1. Clinical and pathological correlation between urinary exosome miR-223 and IgAN patients.
Song J; Qin X; Li H; Huang G; Bi H
Clin Nephrol; 2023 Nov; 100(5):209-215. PubMed ID: 37622669
[TBL] [Abstract][Full Text] [Related]
2. Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy.
Feng Y; Lv LL; Wu WJ; Li ZL; Chen J; Ni HF; Zhou LT; Tang TT; Wang FM; Wang B; Chen PS; Crowley SD; Liu BC
Am J Pathol; 2018 Nov; 188(11):2542-2552. PubMed ID: 30142333
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
Min QH; Chen XM; Zou YQ; Zhang J; Li J; Wang Y; Li SQ; Gao QF; Sun F; Liu J; Xu YM; Lin J; Huang LF; Huang B; Wang XZ
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28383146
[TBL] [Abstract][Full Text] [Related]
4. Exosomal miR-4639 and miR-210 in Plasma and Urine as Biomarkers in IgA Nephropathy.
Zhao S; Sun Y; Mao Q; Zhou C; Chen Y; Xue D
Nephron; 2022; 146(6):539-552. PubMed ID: 35381590
[TBL] [Abstract][Full Text] [Related]
5. Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy.
Duan ZY; Bu R; Liang S; Chen XZ; Zhang C; Zhang QY; Li JJ; Chen XM; Cai GY
Front Immunol; 2024; 15():1326026. PubMed ID: 38426107
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy.
Moon PG; Lee JE; You S; Kim TK; Cho JH; Kim IS; Kwon TH; Kim CD; Park SH; Hwang D; Kim YL; Baek MC
Proteomics; 2011 Jun; 11(12):2459-75. PubMed ID: 21595033
[TBL] [Abstract][Full Text] [Related]
7. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy.
Wang G; Kwan BC; Lai FM; Chow KM; Kam-Tao Li P; Szeto CC
Dis Markers; 2010; 28(2):79-86. PubMed ID: 20364043
[TBL] [Abstract][Full Text] [Related]
8. Urinary Exosomal MicroRNAs as New Noninvasive Biomarkers of IgA Nephropathy.
Li S; Hao H; Li R; Guo S
Tohoku J Exp Med; 2022 Mar; 256(3):215-223. PubMed ID: 35314529
[TBL] [Abstract][Full Text] [Related]
9. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
Liang S; Cai GY; Duan ZY; Liu SW; Wu J; Lv Y; Hou K; Li ZX; Zhang XG; Chen XM
BMC Nephrol; 2017 Feb; 18(1):63. PubMed ID: 28201996
[TBL] [Abstract][Full Text] [Related]
10. Circulating MiR-29a, Possible Use as a Biomarker for Monitoring IgA Nephropathy.
Hu H; Wan Q; Li T; Qi D; Dong X; Xu Y; Chen H; Liu H; Huang H; Wei C; Zhou W; Jiang S; Mo Z; Liao F; Xu Q; He Y
Iran J Kidney Dis; 2020 Mar; 14(2):107-118. PubMed ID: 32165595
[TBL] [Abstract][Full Text] [Related]
11. miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis.
Solé C; Cortés-Hernández J; Felip ML; Vidal M; Ordi-Ros J
Nephrol Dial Transplant; 2015 Sep; 30(9):1488-96. PubMed ID: 26040904
[TBL] [Abstract][Full Text] [Related]
12. Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy.
Wang N; Bu R; Duan Z; Zhang X; Chen P; Li Z; Wu J; Cai G; Chen X
PeerJ; 2015; 3():e990. PubMed ID: 26056621
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy.
Yoon SY; Kim JS; Jung SW; Kim YG; Hwang HS; Moon JY; Lee SH; Seo JW; Seok J; Tae D; Jeong K
Sci Rep; 2023 Oct; 13(1):17201. PubMed ID: 37821628
[TBL] [Abstract][Full Text] [Related]
14. Blood TGF-β1 and miRNA-21-5p levels predict renal fibrosis and outcome in IgA nephropathy.
Bharti N; Agrawal V; Kamthan S; Prasad N; Agarwal V
Int Urol Nephrol; 2023 Jun; 55(6):1557-1564. PubMed ID: 36648741
[TBL] [Abstract][Full Text] [Related]
15. The level of urinary secretory immunoglobulin A (sIgA) of patients with IgA nephropathy is elevated and associated with pathological phenotypes.
Tan Y; Zhang JJ; Liu G; Zhang H; Zhao MH
Clin Exp Immunol; 2009 Apr; 156(1):111-6. PubMed ID: 19196254
[TBL] [Abstract][Full Text] [Related]
16. Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy.
Zhang M; Duan ZY; Zhang QY; Xu XG; Zhang Y; Wang P; Duan SW; Wu J; Chen XM; Cai GY
Sci Rep; 2023 Apr; 13(1):6048. PubMed ID: 37055445
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy.
Guan J; Wang M; Zhao M; Ni W; Zhang M
BMC Nephrol; 2023 Mar; 24(1):60. PubMed ID: 36941570
[TBL] [Abstract][Full Text] [Related]
18. Urinary miRNA profile for the diagnosis of IgA nephropathy.
Szeto CC; Wang G; Ng JK; Kwan BC; Mac-Moune Lai F; Chow KM; Luk CC; Lai KB; Li PK
BMC Nephrol; 2019 Mar; 20(1):77. PubMed ID: 30832601
[TBL] [Abstract][Full Text] [Related]
19. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
Clin J Am Soc Nephrol; 2016 Jun; 11(6):947-955. PubMed ID: 27026518
[TBL] [Abstract][Full Text] [Related]
20. The role of urine IgG in the progression of IgA nephropathy with a high proportion of global glomerulosclerosis.
Xu X; Huang X; Chen Y; Li J; Shen M; Hou Y; Lin X; Lin Q; Liu X; Bao K; Wang L; Yang H; Liu L; Zou C
Int Urol Nephrol; 2022 Feb; 54(2):323-330. PubMed ID: 33871780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
